These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 25716872

  • 1. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E, Grosse B, Schuller B, Davit-Spraul A, Conti F, Guettier C, Cassio D, Jacquemin E.
    Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
    [Abstract] [Full Text] [Related]

  • 2. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
    Gonzales E, Grosse B, Cassio D, Davit-Spraul A, Fabre M, Jacquemin E.
    J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
    [Abstract] [Full Text] [Related]

  • 3. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
    Hayashi H, Sugiyama Y.
    Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
    [Abstract] [Full Text] [Related]

  • 4. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
    Hayashi H, Sugiyama Y.
    Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
    [Abstract] [Full Text] [Related]

  • 5. Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2.
    Naoi S, Hayashi H, Inoue T, Tanikawa K, Igarashi K, Nagasaka H, Kage M, Takikawa H, Sugiyama Y, Inui A, Nagai T, Kusuhara H.
    J Pediatr; 2014 May; 164(5):1219-1227.e3. PubMed ID: 24530123
    [Abstract] [Full Text] [Related]

  • 6. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
    Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, Bernard O, Jacquemin E.
    Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J, Ellinger P, Weissenberger K, Dröge C, Herebian D, Mayatepek E, Homey B, Braun S, Schulte am Esch J, Horacek M, Canbay A, Schmitt L, Häussinger D, Kubitz R.
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [Abstract] [Full Text] [Related]

  • 10. Progressive familial intrahepatic cholestasis.
    Jacquemin E.
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [Abstract] [Full Text] [Related]

  • 11. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
    Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A, Boyer JL.
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological Premature Termination Codon Readthrough of ABCB11 in Bile Salt Export Pump Deficiency: An In Vitro Study.
    Amzal R, Thébaut A, Lapalus M, Almes M, Grosse B, Mareux E, Collado-Hilly M, Davit-Spraul A, Bidou L, Namy O, Jacquemin E, Gonzales E.
    Hepatology; 2021 Apr; 73(4):1449-1463. PubMed ID: 32702170
    [Abstract] [Full Text] [Related]

  • 15. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R, Liu L, Sheps JA, Forrest D, Hofmann AF, Hagey LR, Ling V.
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug 15; 305(4):G286-94. PubMed ID: 23764895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
    Imagawa K, Hayashi H, Sabu Y, Tanikawa K, Fujishiro J, Kajikawa D, Wada H, Kudo T, Kage M, Kusuhara H, Sumazaki R.
    J Hum Genet; 2018 May 15; 63(5):569-577. PubMed ID: 29507376
    [Abstract] [Full Text] [Related]

  • 18. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies.
    Evason K, Bove KE, Finegold MJ, Knisely AS, Rhee S, Rosenthal P, Miethke AG, Karpen SJ, Ferrell LD, Kim GE.
    Am J Surg Pathol; 2011 May 15; 35(5):687-96. PubMed ID: 21490445
    [Abstract] [Full Text] [Related]

  • 19. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.
    Wang L, Soroka CJ, Boyer JL.
    J Clin Invest; 2002 Oct 15; 110(7):965-72. PubMed ID: 12370274
    [Abstract] [Full Text] [Related]

  • 20. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
    Gooijert KE, Havinga R, Wolters H, Wang R, Ling V, Tazuma S, Verkade HJ.
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar 01; 308(5):G450-7. PubMed ID: 25552583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.